Whether the upregulated expression of PD‐L1 at recurrence is due to the survival of immune‐resistant tumor clones via selection pressure at the initial treatment or occurs in a time‐dependent manner remains to be elucidated. This evidence concerns the gene CD274 and neoplasm.